389 related articles for article (PubMed ID: 29947972)
21. Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study.
Liu K; Chen Y; Zeng Y; Xu L; Liu D; Chen H; Zhang X; Han W; Wang Y; Zhao T; Wang J; Wang J; Han Q; Zhao C; Huang X
Stem Cells Dev; 2011 Oct; 20(10):1679-85. PubMed ID: 21142788
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stem Cell Derived Extracellular Vesicles: A Role in Hematopoietic Transplantation?
De Luca L; Trino S; Laurenzana I; Lamorte D; Caivano A; Del Vecchio L; Musto P
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486431
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
Si Y; Yang K; Qin M; Zhang C; Du Z; Zhang X; Liu Y; Yue Y; Feng Z
Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
[TBL] [Abstract][Full Text] [Related]
24. Analysis of multipotent mesenchymal stromal cells used for acute graft-versus-host disease prophylaxis.
Kuzmina LA; Petinati NA; Shipounova IN; Sats NV; Bigildeev AE; Zezina EA; Popova MD; Drize NJ; Parovichnikova EN; Savchenko VG
Eur J Haematol; 2016 Apr; 96(4):425-34. PubMed ID: 26115424
[TBL] [Abstract][Full Text] [Related]
25. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study.
Liu X; Wu M; Peng Y; Chen X; Sun J; Huang F; Fan Z; Zhou H; Wu X; Yu G; Zhang X; Li Y; Xiao Y; Song C; Xiang AP; Liu Q
Cell Transplant; 2014; 23(9):1087-98. PubMed ID: 23294601
[TBL] [Abstract][Full Text] [Related]
26. [Role of Mesenchymal Stem Cells in Preventing GVHD: A Meta-Analysis].
Wang L; Gu ZY; Zhao XL; Wei HP; Luo L; Zhao SS; Liu DH; Wang QS; Gao CJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1125-32. PubMed ID: 26314458
[TBL] [Abstract][Full Text] [Related]
27. Reduced efficacy of mesenchymal stromal cells in preventing graft-versus-host disease in an in vivo model of haploidentical bone marrow transplant with leukemia.
Oviedo A; Yañez R; Colmenero I; Aldea M; Rubio A; Bueren JA; Lamana ML
Cell Transplant; 2013; 22(8):1381-94. PubMed ID: 23044223
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal stromal cells and hematopoietic stem cell transplantation.
Bernardo ME; Fibbe WE
Immunol Lett; 2015 Dec; 168(2):215-21. PubMed ID: 26116911
[TBL] [Abstract][Full Text] [Related]
29. Chimerism of bone marrow mesenchymal stem/stromal cells in allogeneic hematopoietic cell transplantation: is it clinically relevant?
Miura Y; Yoshioka S; Yao H; Takaori-Kondo A; Maekawa T; Ichinohe T
Chimerism; 2013; 4(3):78-83. PubMed ID: 23880502
[TBL] [Abstract][Full Text] [Related]
30. T Cell and Cytokine Dynamics in the Blood of Patients after Hematopoietic Stem Cell Transplantation and Multipotent Mesenchymal Stromal Cell Administration.
Petinati N; Davydova Y; Nikiforova K; Bigildeev A; Belyavsky A; Arapidi G; Drize N; Kuzmina L; Parovichnikova E; Savchenko V
Transplant Cell Ther; 2023 Feb; 29(2):109.e1-109.e10. PubMed ID: 36372356
[TBL] [Abstract][Full Text] [Related]
31. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stromal cells as an adjuvant treatment for severe late-onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation.
Wang Y; Chen F; Gu B; Chen G; Chang H; Wu D
Acta Haematol; 2015; 133(1):72-7. PubMed ID: 25139500
[TBL] [Abstract][Full Text] [Related]
33. Adipose tissue-derived mesenchymal stromal cells as part of therapy for chronic graft-versus-host disease: A phase I/II study.
Jurado M; De La Mata C; Ruiz-García A; López-Fernández E; Espinosa O; Remigia MJ; Moratalla L; Goterris R; García-Martín P; Ruiz-Cabello F; Garzón S; Pascual MJ; Espigado I; Solano C
Cytotherapy; 2017 Aug; 19(8):927-936. PubMed ID: 28662983
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow-derived mesenchymal stem cells decrease acute graft-versus-host disease after allogeneic hematopoietic stem cells transplantation.
Tian Y; Deng YB; Huang YJ; Wang Y
Immunol Invest; 2008; 37(1):29-42. PubMed ID: 18214798
[TBL] [Abstract][Full Text] [Related]
35. [Mesenchymal stem cells for treatment of graft-versus-host disease].
Najima Y
Rinsho Ketsueki; 2017; 58(12):2440-2449. PubMed ID: 29332881
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease.
Ringdén O; Gustafsson B; Sadeghi B
Front Immunol; 2020; 11():567210. PubMed ID: 33193339
[TBL] [Abstract][Full Text] [Related]
37. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
[TBL] [Abstract][Full Text] [Related]
38. Long-term outcomes of antithymocyte globulin in patients with hematological malignancies undergoing myeloablative allogeneic hematopoietic cell transplantation: a systematic review and meta-analysis.
Du K; Hu Y; Wu K; Huang H
Clin Transplant; 2013; 27(2):E91-E100. PubMed ID: 23383989
[TBL] [Abstract][Full Text] [Related]
39. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
40. [Mesenchymal stem cell therapy in hematopoietic stem cell transplantation].
Goto T; Murata M
Rinsho Ketsueki; 2018; 59(2):195-204. PubMed ID: 29515075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
